These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26375888)

  • 21. Immunotoxicity: hazard identification and risk assessment.
    Luster MI; Kimber I
    Hum Exp Toxicol; 1996 Dec; 15(12):947-8. PubMed ID: 8981097
    [No Abstract]   [Full Text] [Related]  

  • 22. The EU REACH system: opportunities and threats.
    Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():1-4. PubMed ID: 16555954
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter to the editor (Wright-Walters et al., 2011).
    Hentges S; Caspers N; Klecka GM; Mihaich EM; Ortego L; Staples CA
    Sci Total Environ; 2013 Apr; 450-451():369-71. PubMed ID: 22704005
    [No Abstract]   [Full Text] [Related]  

  • 24. Policy reforms to update chemical safety testing.
    Nel AE; Malloy TF
    Science; 2017 Mar; 355(6329):1016-1018. PubMed ID: 28280165
    [No Abstract]   [Full Text] [Related]  

  • 25. The biometrical evaluation of the OECD modified version of the acute toxic class method (oral).
    Diener W; Mischke U; Schlede E; Kayser D
    Arch Toxicol; 1995; 69(10):729-34. PubMed ID: 8572934
    [No Abstract]   [Full Text] [Related]  

  • 26. Application of chemometric techniques in studies of toxicity of selected commercially available products for infants and children.
    Szczepańska N; Kudłak B; Nedyalkova M; Simeonov V; Namieśnik J
    Environ Monit Assess; 2017 Jul; 189(7):309. PubMed ID: 28578540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prospects of the use of a quantitative functional-morphological method in the evaluation of toxicity of chemical substances].
    Popuchiyev VV
    Med Tr Prom Ekol; 1995; (12):24-7. PubMed ID: 8673382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of the relationship of properties of chemical compounds and their toxicity to a unified hygienic standardization for chemicals].
    Trushkov VF; Perminov KA; Sapozhnikova VV; Ignatova OL
    Gig Sanit; 2013; (2):87-90. PubMed ID: 24003710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards optimization of chemical testing under REACH: a Bayesian network approach to Integrated Testing Strategies.
    Jaworska J; Gabbert S; Aldenberg T
    Regul Toxicol Pharmacol; 2010; 57(2-3):157-67. PubMed ID: 20156511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis of simple relationships between exposure concentration and toxic effects with time.
    Tennekes HA; Sánchez-Bayo F
    Toxicology; 2013 Jul; 309():39-51. PubMed ID: 23603429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 32. Constructing Time-Resolved Species Sensitivity Distributions Using a Hierarchical Toxico-Dynamic Model.
    Kon Kam King G; Delignette-Muller ML; Kefford BJ; Piscart C; Charles S
    Environ Sci Technol; 2015 Oct; 49(20):12465-73. PubMed ID: 26406398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposal of concentration limits for determining the hazard property HP 14 for waste using ecotoxicological tests.
    Hennebert P
    Waste Manag; 2018 Apr; 74():74-85. PubMed ID: 29221872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bad habits die hard: the NOEC's persistence reflects poorly on ecotoxicology.
    Jager T
    Environ Toxicol Chem; 2012 Feb; 31(2):228-9. PubMed ID: 22095471
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: "Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals".
    Ulmer WR
    Int J Toxicol; 2003; 22(6):475-6; author response 476-8. PubMed ID: 14680995
    [No Abstract]   [Full Text] [Related]  

  • 38. Using toxicological evidence from QSAR models in practice.
    Benfenati E; Pardoe S; Martin T; Gonella Diaza R; Lombardo A; Manganaro A; Gissi A
    ALTEX; 2013; 30(1):19-40. PubMed ID: 23338804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse outcome pathways: hype or hope?
    Vinken M; Whelan M; Rogiers V
    Arch Toxicol; 2014 Jan; 88(1):1-2. PubMed ID: 23868017
    [No Abstract]   [Full Text] [Related]  

  • 40. Don't be fooled-A no-observed-effect concentration is no substitute for a poor concentration-response experiment.
    Fox DR; Landis WG
    Environ Toxicol Chem; 2016 Sep; 35(9):2141-8. PubMed ID: 27089534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.